Effectiveness of the Ronnie Gardiner Method for elderly psychiatric patients
Improving Cognitive and Emotional Processing in Older (Psychiatric) Patients: the Transdiagnostic Effectiveness of the Ronnie Gardiner Method (RGM).
This study is testing if the Ronnie Gardiner Method can help improve thinking skills and emotional control in older adults with psychiatric conditions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Tienen, Vlaams-Brabant) |
| Trial ID | NCT04927533 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility and effectiveness of the Ronnie Gardiner Method (RGM) in improving executive functions among Flemish psychogeriatric patients aged 60 and older. Participants will receive RGM treatment without a control group, as all patients in the clinic are entitled to this intervention. The study aims to observe significant improvements in core executive functions and emotion regulation, hypothesizing that increased participation in RGM sessions will correlate with greater benefits. The research will also explore the mediating role of executive functions in the relationship between session attendance and emotion regulation improvement.
Who should consider this trial
Good fit: Ideal candidates are psychogeriatric inpatients aged 60 and older who are fluent in Dutch and do not have moderate to severe cognitive impairments.
Not a fit: Patients with moderate to severe cognitive impairments, those not fluent in Dutch, or those who have undergone recent surgery or chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance cognitive and emotional well-being in elderly patients with psychiatric disorders.
How similar studies have performed: While the specific effectiveness of the Ronnie Gardiner Method has not been widely tested, similar approaches focusing on cognitive and emotional improvements in elderly populations have shown promise.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Psychogeriatric inpatients aged 60+ Exclusion Criteria: * Checking for moderate to severe cognitive impairments (exclusion criterion) using the Mini-Mental State Examination (MMSE; Folstein, Folstein, \& McHugh, 1975; Dutch version: Kok and Verhey, 2002), following exclusion criterion applies: a score of less than 21 on the MMSE (excluding dementia or other moderate to severe cognitive impairment) * Not fluent in Dutch * Having undergone surgery and/or chemotherapy in the last three months.
Where this trial is running
Tienen, Vlaams-Brabant
- Alexianen Zorggroep Tienen — Tienen, Vlaams-Brabant, Belgium (Recruiting)
Study contacts
- Principal investigator: Xenia Brancart — Vrije Universiteit Brussel - Ghent University
- Study coordinator: Xenia Brancart
- Email: xenia.christiane.brancart@vub.be
- Phone: +32475791763
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.